Cell therapeutic approaches to immunosuppression after clinical kidney transplantation-Reference-Cited by-同舟云学术

Cell therapeutic approaches to immunosuppression after clinical kidney transplantation

Published:2017-02-23 Issue:2 Volume:33 Page:199-213
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Morath Christian,Schmitt Anita,Kälble Florian,Zeier Martin,Schmitt Michael,Sandra-Petrescu Flavius,Opelz Gerhard,Terness Peter,Schaier Matthias,Kleist Christian

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/article/10.1007/s00467-017-3599-2/fulltext.html

Reference96 articles.

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730

2. Morath C, Schmitt A, Zeier M, Schmitt M, Sandra-Petrescu F, Opelz G, Terness P, Schaier M, Kleist C (2015) Cell therapy for immunosuppression after kidney transplantation. Langenbecks Arch Surg 400:541–550

3. Billingham RE, Brent L, Medawar PB (1953) Actively acquired tolerance of foreign cells. Nature 172:603–606

4. Pearl JP, Preston E, Kirk AD (2003) Tolerance: is it achievable in pediatric solid organ transplantation? Pediatr Clin N Am 50:1261–1281

5. Girlanda R, Kirk AD (2007) Frontiers in nephrology: immune tolerance to allografts in humans. J Am Soc Nephrol 18:2242–2251

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of efferocytosis and transplant rejection: Strategies in promoting transplantation tolerance using apoptotic cell therapy and/or synthetic particles;Cell Biochemistry and Function;2023-10-03

2. Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation;Frontiers in Immunology;2023-07-11

3. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial;BMJ Open;2022-11

4. Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients;Journal of the American Society of Nephrology;2022-09-22

5. Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models;Scientific Reports;2022-05-04